These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 14983044)

  • 1. Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.
    Sui J; Li W; Murakami A; Tamin A; Matthews LJ; Wong SK; Moore MJ; Tallarico AS; Olurinde M; Choe H; Anderson LJ; Bellini WJ; Farzan M; Marasco WA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2536-41. PubMed ID: 14983044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.
    Sui J; Li W; Roberts A; Matthews LJ; Murakami A; Vogel L; Wong SK; Subbarao K; Farzan M; Marasco WA
    J Virol; 2005 May; 79(10):5900-6. PubMed ID: 15857975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.
    Lim HT; Kok BH; Lim CP; Abdul Majeed AB; Leow CY; Leow CH
    Biomed Eng Adv; 2022 Dec; 4():100054. PubMed ID: 36158162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus.
    Rani M; Bolles M; Donaldson EF; Van Blarcom T; Baric R; Iverson B; Georgiou G
    J Virol; 2012 Sep; 86(17):9113-21. PubMed ID: 22696652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.
    Hwang WC; Lin Y; Santelli E; Sui J; Jaroszewski L; Stec B; Farzan M; Marasco WA; Liddington RC
    J Biol Chem; 2006 Nov; 281(45):34610-6. PubMed ID: 16954221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
    Zhu Z; Chakraborti S; He Y; Roberts A; Sheahan T; Xiao X; Hensley LE; Prabakaran P; Rockx B; Sidorov IA; Corti D; Vogel L; Feng Y; Kim JO; Wang LF; Baric R; Lanzavecchia A; Curtis KM; Nabel GJ; Subbarao K; Jiang S; Dimitrov DS
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12123-8. PubMed ID: 17620608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
    Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
    Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
    Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
    Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage.
    Lee YC; Leu SJ; Hung HC; Wu HH; Huang IJ; Hsieh WS; Chiu WT; Hsieh MS; Cheng TF; Yang YY
    Vet Immunol Immunopathol; 2007 May; 117(1-2):75-85. PubMed ID: 17360045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.